Albert Bourla, Pfizer CEO (John Thys, Pool via AP Images)

Covid-19 roundup: No­vavax may not go to FDA un­til June at ear­li­est — re­port; Bourla push­es back against IP waiv­er in pub­lic let­ter

Pub­lic health of­fi­cials hop­ing to roll­out No­vavax’s Covid-19 vac­cine will have to wait a bit longer. The com­pa­ny will not file for au­tho­riza­tion with the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.